Methylene Blue.
A mitochondrial enhancer for cognitive stamina, energy, and oxidative-stress protection.
Pricing is shown after your free assessment, before you commit.
Free to start. No card required.
Reviewed by Lumora clinical team (Licensed provider network)Mixed evidenceSource: Client-approved product catalog; provider review required
Evidence, regulatory status, and fit vary by medication, formulation, route, and individual history.
Is this for you?
This is for you if
- Patients with brain fog or low energy
- Patients wanting improved mental clarity and mood
- Patients pursuing mitochondrial and anti-aging support
- Patients with long, cognitively demanding workdays
This isn't for you if
Avoid combining with SSRIs, MAOIs, or other serotonergic medications (serotonin syndrome risk). Patients with G6PD deficiency should not use. Disclose all medications before starting.
Methylene Blue
Methylene Blue is a long-studied compound that supports mitochondrial energy production and brain function. It has antioxidant and anti-inflammatory properties and helps neurons use oxygen more efficiently.
Mechanism and fit.
Methylene Blue improves mitochondrial electron transport — the cellular process that produces ATP. This increases energy yield per unit of fuel and reduces oxidative stress, supporting clearer thinking, sharper memory, and better cognitive endurance.
Who this is typically for.
- Patients with brain fog or low energy
- Patients wanting improved mental clarity and mood
- Patients pursuing mitochondrial and anti-aging support
- Patients with long, cognitively demanding workdays
What patients
most often ask.
Why can't I take Methylene Blue with antidepressants?
Methylene Blue has MAO-inhibitor activity. Combining it with SSRIs, SNRIs, or other serotonergic medications can cause serotonin syndrome — a serious reaction. Disclose all medications before starting.
Who this is typically for.
These are common fit patterns from the approved catalog. Your provider determines whether treatment is appropriate.
- <ul><li>Patients with brain fog or low energy</li><li>Patients wanting improved mental clarity and mood</li><li>Patients pursuing mitochondrial and anti-aging support</li><li>Patients with long, cognitively demanding workdays</li></ul>
How this option
is evaluated.
The plan is provider-determined after reviewing your assessment and safety factors.
- DosingDaily or every other day, form-dependent, provider-directed.
- Typical duration4–12 weeks, or as needed.
- Safety and eligibilityYour provider reviews contraindications, medication interactions, goals, and safety factors before prescribing.
- A licensed provider reviews your assessment before any treatment is recommended.
- You see full pricing - visit fees, medication, labs, follow-up - before you commit.
- Your plan can be adjusted, paused, or stopped based on response and safety. Your clinician is reachable - not a chatbot.
- Compounded medications are not FDA-approved and are dispensed only when prescribed by a licensed provider.
Start with
provider review.
If you are considering Methylene Blue, the first step is a free assessment. A provider determines whether it fits your goals and medical history.
A provider determines whether treatment is clinically appropriate.